News
In MS, iron-ringed lesions may add to imaging toolkit
STOCKHOLM – Brain lesions with iron rings were detected only in MRI scans of MS patients.
News
How to distinguish Stevens-Johnson syndrome from its mimickers
NEW YORK – Clinical clues and a careful history can calm concerns when Stevens-Johnson syndrome is suspected.
News
In PAD, dropping statins ups death risk 43%
PARIS – Statin adherence saves lives in peripheral arterial disease.
News
Ticagrelor: Modest benefit, bigger bleed risk in diabetes plus stable CAD
Patients with prior PCI fared a bit better and may be a target population for long-term DAPT therapy.
News
Early post-ACS bleeding may signal cancer
PARIS – Cancer risk is elevated with bleeding, whether or not DAPT is employed
Video
Over decades, low physical activity boosts mortality risk
PARIS – Being active in earlier adulthood didn’t save sedentary older adults from increased risk.
News
In vasculitis, the skin tells the story
MILAN – Confirmatory lab testing – and assessing for renal involvement – are still paramount, however.
News
Most authors of endoscopy practice guidelines have undisclosed financial conflicts
SAN DIEGO – Authors of endoscopy clinical practice guidelines (CPGs) received many more payments from industry than...
News
Clues to eczematous cheilitis may lie in the history
NEW YORK – The itch, flake, and swelling of eczematous cheilitis merit some detective work.
News
What’s the best way to sort out red nail discoloration?
NEW YORK – Start by seeing whether one nail, or many, have longitudinal erythronychia.
News
Consider adding chemical peels for your acne patients
MILAN – A series of light peels can be a good boost to a multi-pronged acne treatment regimen.
News
Beyond C. difficile: The future of fecal microbial transplantation
SAN DIEGO – Future directions for microbial transplantation range from multifactorial and functional gut disorders to consideration of the small...
Audio
Lenabasum, a novel cannabinoid, shows promise in dermatomyositis
MILAN – Promising early clinical work has paved the way for a global phase 3 trial.